Lataa...
Chemotherapy in patients with hepatobiliary cancers and abnormal hepatic function
Sorafenib and cisplatin plus gemcitabine currently represent first-line treatment standards in advanced hepatocellular carcinoma and biliary cancer, respectively. Conventional cytotoxic agents (monotherapy or combination therapy) have demonstrated activity in the second-line setting or in those in w...
Tallennettuna:
| Julkaisussa: | J Gastrointest Oncol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
AME Publishing Company
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5401853/ https://ncbi.nlm.nih.gov/pubmed/28480070 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2016.09.17 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|